HutchMed – formerly Hutchison China MediTech – saw its share price jump 50% on debut after raising HK$4.17 billion ($536.9 million) through a Hong Kong share offering.
The company, which already trades in the US and London, sold 104 million new shares for HK$40.10 apiece, according to a filing. Cornerstone investors covered 61% of the offering. They included The Carlyle...
Black Sesame Technologies, a China-based chipmaker specializing in autonomous driving applications, has closed a Series C extension led by SummitView Capital. This brings the size of the overall round to USD 500m.
Japanese lower middle-market private equity firm J-Star has made an investment of undisclosed size in air cargo transportation and courier services provider Score Japan Holdings.
Gaorong Capital and Tsing Song Capital have led a CNY 500m (USD 74m) Series C for IntellectiveBio, a China-based contract development and manufacturing organisation (CDMO).
Morningside Venture Capital has teamed up with Kingray Capital, Trinity Innovation Fund, TigerYeah Capital, and FountainBridge Capital to provide USD 20m in angel and pre-Series A funding for Epigenic Therapeutics, a China-based gene editing specialist.